Published in Appl Environ Microbiol on November 01, 1993
Effects of temperature and salinity on Vibrio vulnificus population dynamics as assessed by quantitative PCR. Appl Environ Microbiol (2004) 1.45
A selective medium and a specific probe for detection of Vibrio vulnificus. Appl Environ Microbiol (2000) 1.10
Improved isolation of Vibrio vulnificus from seawater and sediment with cellobiose-colistin agar. Appl Environ Microbiol (1998) 1.00
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Effect of temperature and salinity on Vibrio (Beneckea) vulnificus occurrence in a Gulf Coast environment. Appl Environ Microbiol (1982) 5.17
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Distribution of Vibrio vulnificus and other lactose-fermenting vibrios in the marine environment. Appl Environ Microbiol (1983) 4.30
Correlation between virulence and colony morphology in Vibrio vulnificus. Infect Immun (1987) 3.93
Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis (1984) 3.69
Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect Immun (1985) 3.69
Isolation and characterization of Vibrio vulnificus from two Florida estuaries. Appl Environ Microbiol (1982) 3.58
Enzyme immunoassay for identification of Vibrio vulnificus in seawater, sediment, and oysters. Appl Environ Microbiol (1991) 2.61
New selective and differential medium for Vibrio cholerae and Vibrio vulnificus. Appl Environ Microbiol (1987) 2.54
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Evidence for the presence of a capsule in Vibrio vulnificus. J Gen Microbiol (1984) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
Use of colistin-polymyxin B-cellobiose agar for isolation of Vibrio vulnificus from the environment. Appl Environ Microbiol (1992) 1.45
Thiosulfate-citrate-bile salts-sucrose agar and its selectivity for clinical and marine vibrio organisms. Ann Clin Lab Sci (1983) 1.14
New selective plating medium for isolation of Vibrio vulnificus biogroup 1. J Clin Microbiol (1983) 1.12
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Membrane filter procedure for enumeration of Aeromonas hydrophila in fresh waters. Appl Environ Microbiol (1979) 1.89
Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis (1990) 1.45
Effect of fecal pollution on Vibrio parahaemolyticus densities in an estuarine environment. Appl Environ Microbiol (1985) 1.43
Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem (1995) 1.41
Atrial natriuretic peptide plasma levels during cardiac surgery. J Cardiothorac Anesth (1988) 1.40
Occurrence of male-specific bacteriophage in feral and domestic animal wastes, human feces, and human-associated wastewaters. Appl Environ Microbiol (1998) 1.38
Membrane filter procedure for enumeration of Vibrio parahaemolyticus. Appl Environ Microbiol (1976) 1.38
A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr (1973) 1.34
Novel compound for identifying Escherichia coli. Appl Environ Microbiol (1988) 1.28
Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science (1982) 1.23
Seasonal effects on accumulation of microbial indicator organisms by Mercenaria mercenaria. Appl Environ Microbiol (1992) 1.22
A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology (1997) 1.19
Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care. Anesthesiology (1997) 1.19
Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension. Lancet (1980) 1.18
Thromboxane release during percutaneous transluminal coronary angioplasty. Am Heart J (1986) 1.06
Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology (1994) 1.02
Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Prostaglandins (1982) 0.98
Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest (1981) 0.97
Prostaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg (1985) 0.94
Benchmarking the perioperative process: III. Effects of regional anesthesia clinical pathway techniques on process efficiency and recovery profiles in ambulatory orthopedic surgery. J Clin Anesth (1998) 0.94
Eicosanoids in the central nervous system. J Neurosurg (1985) 0.93
Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow. J Thorac Cardiovasc Surg (1982) 0.93
Inhibition by nicardipine of endothelin-mediated inositol phosphate formation and Ca2+ mobilization in smooth muscle cell. Biochem Biophys Res Commun (1989) 0.91
Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep. Circ Res (1982) 0.91
The operating rooms: cost center management in a managed care environment. Int Anesthesiol Clin (1995) 0.91
Regulation of endothelin-mediated calcium mobilization in vascular smooth muscle cells by isoproterenol. Am J Physiol (1991) 0.91
Experimental methanol toxicity in the primate: analysis of metabolic acidosis. Toxicol Appl Pharmacol (1975) 0.89
Superoxide-induced changes in endothelin (ET) receptors in hepatic stellate cells. J Hepatol (1998) 0.88
Remifentanil as an analgesic adjunct in local/regional anesthesia and in monitored anesthesia care. Anesth Analg (1999) 0.88
Evaluation of solutions for small intestinal preservation. Biochemical changes as a function of storage time. Transplantation (1991) 0.87
Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma. Biochem Biophys Res Commun (1989) 0.86
Nitric oxide and intracellular heme. Adv Pharmacol (1995) 0.85
Survival and replication of male-specific bacteriophages in molluscan shellfish. Appl Environ Microbiol (1992) 0.85
Methylprednisolone on circulating eicosanoids and vasomotor tone after endotoxin. J Appl Physiol (1985) (1986) 0.85
Thromboxane generation after thrombin. Protective effect of thromboxane synthetase inhibition on lung fluid balance. Circ Res (1983) 0.85
Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord. J Pharmacol Exp Ther (1990) 0.84
Intravenous labetalol for treatment of postoperative hypertension. Anesthesiology (1987) 0.84
Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors. Anesthesiology (1992) 0.83
Fluorescent/ultraviolet absorbing ester derivative formation and analysis of eicosanoids by high-pressure liquid chromatography. Anal Biochem (1982) 0.83
Effects of leukotrienes B4 and C4 on coronary circulation and myocardial contractility. Surgery (1983) 0.83
Microdialysis measurements of PGD2, TXB2 and 6-KETO-PGF1 alpha in rat CA1 hippocampus during transient cerebral ischemia. Prostaglandins (1993) 0.83
Diclofenac sodium (Voltaren) reduced exercise-induced injury in human skeletal muscle. Med Sci Sports Exerc (2000) 0.82
Role of the intracellular distribution of hepatic catalase in the peroxidative oxidation of methanol. Ann N Y Acad Sci (1969) 0.82
Ibuprofen pretreatment inhibits prostacyclin release during abdominal exploration in aortic surgery. Anesthesiology (1990) 0.81
Alcohol metabolism: role of microsomal oxidation in vivo. Science (1969) 0.81
Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs. Stroke (1987) 0.81
Toxicity of emetine to isolated embryonic chick-heart cells. J Pharm Sci (1968) 0.81
Biochemical appraisal of models for hepatic ischemia-reperfusion injury. Circ Shock (1992) 0.81
Studies on the properties of retinal alcohol dehydrogenase from the rat. J Neurochem (1971) 0.80
Benchmarking the perioperative process. I. Patient routing systems: a method for continual improvement of patient flow and resource utilization. J Clin Anesth (1997) 0.80
Hemodynamics and prostacyclin release in the early phases of aortic surgery: comparison of transabdominal and retroperitoneal approaches. J Vasc Surg (1988) 0.80
Thromboxane and prostacyclin (epoprostenol) during exercise in diffuse pulmonary fibrosis. Lancet (1982) 0.79
Purification of opioid receptor in the presence of sodium ions. Life Sci (1992) 0.79
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry (1986) 0.78
Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology (1996) 0.78
A pertussis/cholera toxin sensitive G-protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cell. Biochem Biophys Res Commun (1987) 0.78
Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors. J Pharmacol Exp Ther (1987) 0.78
Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes. J Pharmacol Exp Ther (1992) 0.78
Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate. J Pharmacol Exp Ther (1994) 0.78
Comparative chemical and toxicological evaluation of residual ethylene oxide in sterilized plastics. J Pharm Sci (1969) 0.78
Inhibition of methanol and ethanol oxidation by pyrazole in the rat and monkey in vivo. Mol Pharmacol (1970) 0.78
Pulmonary hypertension and prostaglandins after protamine. Am J Cardiol (1986) 0.77
Benchmarking the perioperative process: II. Introducing anesthesia clinical pathways to improve processes and outcomes and to reduce nursing labor intensity in ambulatory orthopedic surgery. J Clin Anesth (1998) 0.77
Reduced plasma thromboxane elevation during partial cardiopulmonary bypass in thrombocytopenic sheep. Trans Am Soc Artif Intern Organs (1981) 0.77
Eicosanoids and the hemodynamic course of live Escherichia coli-induced sepsis in baboons. Circ Shock (1989) 0.77
Metabolism of pyrazole. Structure elucidation of urinary metabolites. Drug Metab Dispos (1977) 0.76
The toxicity of flavonoids to guinea pig enterocytes. Toxicol Appl Pharmacol (1989) 0.75
Leukotriene D4: a potent sheep coronary vasoconstrictor not blocked by ibuprofen. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.75
Pharmacokinetic studies of the disposition of secobarbital in the dog. Drug Metab Dispos (1975) 0.75
The role of pharmacoepidemiology research in postmarketing surveillance and anesthesia practice/critical care medicine. Anesth Analg (1993) 0.75
Prostaglandin response to intravenous nitroglycerin. J Surg Res (1982) 0.75
Effect of experimental cardiopulmonary bypass on systemic and transcardiac thromboxane B2 levels. J Thorac Cardiovasc Surg (1986) 0.75
Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord. NIDA Res Monogr (1986) 0.75
A surgical services management system--toward improved communications and operational efficiency. Proc Annu Symp Comput Appl Med Care (1994) 0.75
Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung. J Appl Physiol (1985) (1993) 0.75
Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion. Am J Physiol (1982) 0.75
Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass. Trans Am Soc Artif Intern Organs (1980) 0.75
Pharmacology of pyrazoles. I. Structure elucidation of metabolites of 4-methylpyrazole. Biochem Biophys Res Commun (1972) 0.75
Effect of epidural lidocaine on spinal cord blood flow. Anesth Analg (1989) 0.75
Regional blood flow and pulmonary thromboxane release after sublethal endotoxin infusion in sheep. Surgery (1984) 0.75
Complement depletion prevents pulmonary hypertension and leukopenia in sheep extracorporeal membrane oxygenation. Trans Am Soc Artif Intern Organs (1983) 0.75
Eicosanoids (prostaglandins) and the cardiovascular system. J Card Surg (1986) 0.75
Effect of lung thromboxane generation on regional blood flow during sheep bypass. Am J Physiol (1982) 0.75
Pulmonary vasoconstriction and profound leukopenia in two sheep experimental models. Effects of complement depletion. Chest (1983) 0.75
Transpulmonary prostaglandin F2 alpha metabolism in sheep: an in vivo model. Prostaglandins Leukot Essent Fatty Acids (1989) 0.75
Cardiac prostacyclin kinetics during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1984) 0.75
Inhibition of thromboxane A2 production does not improve post-ischemic brain hypoperfusion in the dog. Stroke (1987) 0.75
Absence of prostaglandin changes associated with protamine administration in patients with pulmonary hypertension. J Cardiothorac Anesth (1987) 0.75